|Gefen Biomed Investments Ltd -- Israel Stock|| |
null 4.80 0.00 0.00%
Mr. Meni More serves as Chief Executive Officer at Gefen Biomed Investments Ltd since January 23 2013. Previously he served as Director at the Company from March 28 2010 until February 23 2011. He also serves as Director at Nextgen Biomed Ltd. since January 17 2010 and at Biomedix Incubator Ltd. since January 30 2007.
Age: 51 CEO Since 2013
972 8 675 1122 http://www.gefenbiomed.com
The company has return on total asset (ROA)
of 20.33 %
which means that it generated profit of $20.33 on every $100 spent on asset. This is normal as compared to the sector avarege.
The company has accumulated 20.23 M in total debt with debt to equity ratio (D/E) of 0.49 which is about average as compared to similar companies. Gefen Biomed Investments Ltd has Current Ratio of 0.58 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Gefen Biomed Investments Ltd engages in the location, screening, and investment in earlystage medical devices and biotechnology companies. Gefen Biomed Investments Ltd (GEFEN) is traded on Tel Aviv Stock Exchange in Israel. It is located in Ashkelon, and employs 12 people.